Hot Life Science Investor Mandate 1: Family Office Seeking Medical Device Opportunities Nearing Commercialization

28 Aug

A Family office based in the United States focuses on investments in the healthcare industry. The firm’s investment size can vary greatly and is very flexible depending on each company’s needs. The firm provides venture growth capital to healthcare companies and typically invests in equity or convertible preferred equity after the series A round. For growth investments, the firm targets companies with compelling products and strong position in niche markets and with an EBITDA in excess of $2 million. The firm primarily invests in companies based in US.

The firm will consider investments in Medical Devices, Diagnostics and Healthcare IT sectors. For early-stage investments, the firm targets companies that provide solutions for hospital acquired infections, medication errors, patient monitoring, healthcare system operational efficiency enhancements and cost reductions, and chronic disease management. The firm does not invest in companies developing small molecule or devices that need PMA. For medical device sector, the firm is most interested in class I and class II devices. The firm will not consider companies in pre-clinical stage, and typically invests in companies that are near or have reached commercialization.

The firm focuses on private companies with strong and experienced management team. The firm usually takes a board seat post investment.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: